Green Valley Investors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$80.2M Hold
887,659
4.56% 9
2019
Q2
$105M Sell
887,659
-148,124
-14% -$14.9M 5.96% 5
2019
Q1
$89.7M Hold
1,035,783
4.58% 7
2018
Q4
$65.4M Sell
1,035,783
-419
-0% -$28.8K 3.75% 9
2018
Q3
$81.8M Buy
1,036,202
+173,302
+20% +$11.3M 3.65% 11
2018
Q2
$51.6M Sell
862,900
-60,804
-7% -$3.27M 2.42% 14
2018
Q1
$37.3M Hold
923,704
1.78% 21
2017
Q4
$48.5M Sell
923,704
-41,646
-4% -$2.22M 2.31% 16
2017
Q3
$45.5M Buy
965,350
+374,666
+63% +$15.1M 2.22% 16
2017
Q2
$20.9M Buy
+590,684
New +$18.2M 1.02% 26

Other funds holding EXAS

Green Valley Investors's EXAS Position: Q3 2019 in Review

Green Valley Investors held its Exact Sciences (EXAS) position steady in Q3 2019 at 887,659 shares worth $80.2M. The position accounts for 4.56% of the portfolio, ranked #9.

Green Valley Investors first reported a position in EXAS in Q2 2017 and has held it in 10 quarters since. The position peaked at $105M in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Green Valley Investors held 887,659 shares of Exact Sciences worth $80.2M as of Q3 2019.
  • Green Valley Investors left its Exact Sciences share count unchanged in Q3 2019.
  • Exact Sciences made up 4.56% of Green Valley Investors's portfolio in Q3 2019, its #9 holding.
  • Green Valley Investors first reported a position in Exact Sciences in Q2 2017 and has held it in 10 quarters since.
  • Green Valley Investors's Exact Sciences position peaked at $105M in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Green Valley Investors's 13F filing for Q3 2019, filed 13 Nov 2019.